Hjem › Leverkreft › Missouri › St. Louis
Kliniske studier for Leverkreft i St. Louis, MO
8 studier for Leverkreft søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
RekruttererFase 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- og 5 flere
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
RekruttererFase 1
- Washington University /ID# 275757, St Louis
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Rekrutterer
- Siteman Cancer Center Washington University, St Louis
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RekruttererFase 1
- Washington University School of Medicine, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RekruttererObservasjonsstudie
- Washington University School of Medicine, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
RekruttererObservasjonsstudie
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, St Louis
Leverkreft-studier i andre byer
- Houston, TX14 studier
- Los Angeles, CA11 studier
- Cleveland, OH11 studier
- Dallas, TX10 studier
- Boston, MA9 studier
- Chicago, IL8 studier
- Durham, NC7 studier
- Philadelphia, PA7 studier
- San Francisco, CA6 studier
- New York City, NY6 studier
- Washington, DC6 studier
- Orange, CA6 studier
Andre studier i St. Louis
- Ikke-småcellet lungekreft73 studier
- Brystkreft64 studier
- Metastatisk kreft54 studier
- Kolorektal kreft50 studier
- Kreft (alle typer)46 studier
- Prostatakreft46 studier
- Lungekreft39 studier
- Eggstokkreft38 studier
- Pankreaskreft33 studier
- Endometriekreft29 studier
- Plateepitelcancer i hode og hals28 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.